NICE has recommended a new treatment option for moderate to severe chronic hand eczema, saying it could ‘transform’ patients’ life. An estimated 62,000 patients could be eligible for delgocitinib ...

LEO Pharma has received Technology Appraisal Guidance (TAG) from the National Institute for Health and Care Excellence (NICE) for Anzupgo (delgocitinib) cream. The decision means Anzupgo is now ...

More than 62,000 people in England with debilitating hand eczema could benefit from a new treatment that has been given the go-ahead to be rolled out on the NHS. The recommendation for delgocitinib, ...

Chronic hand eczema causes the hands to become dry, sore, cracked and itchy, making tasks difficult. Hand eczema causes the hands to become dry, sore, cracked and itchy (Alamy/PA) More than 62,000 ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

· The National Institute for Health and Care Excellence (NICE) has approved the first-and-only topical treatment of its kind in adults with moderate to severe Chronic Hand Eczema (CHE) when topical ...

The first cream created to treat hand eczema is to be rolled out on the NHS after winning approval from the health watchdog. Trials show the cream, delgocitinib, significantly reduces itchiness and ...

What Is Opzelura, and Why Does It Matter? Opzelura (ruxolitinib) is a prescription cream that helps reduce skin inflammation. It works by blocking certain proteins in the body called Janus kinases ...

Sept 18 (Reuters) - The U.S. Food and Drug Administration has approved Incyte's (INCY.O), opens new tab eczema cream for children aged between 2 and 11 years, the company said on Thursday. Wilmington, ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...